An official with the U.S. covid-19 vaccine initiative said anyone in the country who wants a vaccine will be able to receive it in June, seven months from now.
The confident screening was made by retired Lt. Gen. Paul Ostrowski, director of supply, production and distribution for Operation Warp Speed, during an apparition on MSNBC Monday, November 30.
“One hundred percent of Americans who want the vaccine will have already received it by then,” Ostrowksi said, adding that the United States would get more than 300 million doses for that to happen.
The prediction, if true, could point to a way out of the pandemic, but it also heralds a period ahead of people who have and don’t have vaccines around the world. In a statement, the World Health Organization said it believes vaccines should be a priority for people at high risk of infection or death, wherever they are, rather than vaccinating “populations. whole of some countries while everyone else does. row”.
The Geneva-based health agency is involved in a program to purchase and distribute vaccines in nearly 200 counties, half of which are poor, but says it believes population-level vaccination will not take place than in 2022. “We’re seeing a very low vaccine supply in the next six months and it will take a year to start covering 15-20% of the world’s population,” the WHO said.
Related Downloads:
So far, two genetic vaccines, one from Pfizer and the other from Moderna Pharmaceuticals, are awaiting approval from the United States Food and Drug Administration. Following spectacular results which have shown that they have avoided around 95% of cases of covid19.
While supplies of these two vaccines will be limited in the coming months, the United States has purchased much of Pfizer’s initial supply and all of Moderna’s 100 million first doses. Together, the two companies predict that they will have enough vaccines to immunize 1 billion people by the end of 2021.
It’s unclear whether the June screening from the head of Operation Warp Speed only referred to these two vaccines, or whether reaching the summer target would require clearance for a third vaccine. One of the pioneers, manufactured by AstraZeneca, is easier to manufacture in large quantities (the United States has contracted 300 million doses) but the first results suggest that it is less effective and errors in your judgment this could delay a final response.
A spokesperson for the US Department of Health and Human Services said Ostrowski’s comment was based “on the best assessment of vaccine doses available,” but did not specify which products the companies were being considered.
Some were skeptical of Warp Speed’s claim that vaccines were widely available in June, pointing to previous false promises by the US administration, including that the pandemic would end before Easter. then for remembrance day
as well as President Donald Trump’s promise in March that “anyone who wants a test can do it. In reality, there was a shortage of test materials and long waits for results.
Topher Spiro, vice president of health policy at the Center for American Progress, tweeted that Warp Speed’s statement “isn’t true.” Spiro has predicted a shortage of syringes and needles, and the lack of funds for the mass vaccination program, in parking lots or community centers, he says will be necessary. “We cannot vaccinate hundreds of millions of people in doctors’ offices and pharmacies” in a short time, Spiro aware and Twitter.
While the covid-19 vaccination campaign is unprecedented in many ways, the medical industry can reach large masses of people with vaccines. Each year, for example, about half of Americans receive a flu shot.
It’s unclear how many people will sign up to receive a covid-19 vaccine, and ‘widespread vaccine rejection’ could end up making it easier for Warp Speed to deliver on its June supply pledge for anyone. “Wants” the vaccine. According to an October Gallup pollOf 2,985 adults, only six in 10 Americans said they would agree to be vaccinated with an FDA-approved vaccine.
However, other experts said they believed a June target was realistic. “I think they will have a vaccine in America, but the whole world will not have one,” said Mark Emalfarb, CEO of a company, Dyadic, involved in the manufacture of vaccines. “If we want to travel between countries, we have to vaccinate most of the world, or all.
Emalfarb says he anticipates public confusion as people try to weigh the pros and cons of each vaccine, if given a choice. “We’re going to have a bunch of different vaccines because none of these types can produce enough,” he says.
Many are hopeful that a vaccine will end the pandemic, but for the foreseeable future, further public health measures will still be needed to suppress the spread of the virus. Considering rampant infection levels in the United States, an estimated 50 million Americans have already contracted the virus. By June, that number could double to a third of the country’s population.
The incoming administration of President-elect Joe Biden has said it wants to spend $ 25 billion on the manufacture and distribution of vaccines to “ensure” that all Americans receive a free injection. In the recent MSNBC interview, Ostrowski said he briefed Biden’s incoming team during Thanksgiving week.